Skip to main content
TipRanks
Go Ultimate75% OFF

ORIENTBIO, Inc. (002630) Income Statement

ORIENTBIO, Inc. Income Statement

Last quarter (Q1 2026), ORIENTBIO, Inc.'s total revenue was ₩6.59B, a decrease of 14.19% from the same quarter last year. In Q1, ORIENTBIO, Inc.'s net income was ₩4.85B. See ORIENTBIO, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
₩ 29.75B₩ 29.40B₩ 28.01B₩ 28.82B₩ 26.28B
₩ 3.96B₩ 7.20B₩ 9.58B₩ 9.82B₩ 9.01B
₩ 8.40B₩ 10.27B₩ 10.23B₩ 8.37B₩ 12.79B
Depreciation and Amortization₩ 2.20B₩ 1.95B₩ 2.68B₩ 3.09B₩ 3.93B
₩ -2.24B₩ -11.02B₩ 15.67B₩ -9.25B₩ 997.25M
₩ -4.44B₩ -3.08B₩ -645.95M₩ 1.45B₩ -3.78B
₩ -125.19M₩ -10.12B₩ 13.52B₩ -14.04B₩ 419.55M
₩ -4.57B₩ -13.19B₩ 12.87B₩ -12.59B₩ -3.36B
₩ -4.57B₩ -13.19B₩ 12.87B₩ -12.42B₩ 34.20B
Per Share Metrics
Basic EPS₩ -154.06₩ -445.14₩ 434.22₩ -419.12₩ -52.58
Diluted EPS₩ -154.06₩ -445.14₩ 434.22₩ -419.12₩ -52.58
Weighted Average Shares Outstanding29.64M29.64M29.64M29.64M29.65M
Weighted Average Shares Outstanding (Diluted)29.64M29.64M29.64M29.64M29.65M

Currency in KRW

ORIENTBIO, Inc. Earnings and Revenue History

-80B080B160B-80 %0 %80 %160 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin